首页> 美国卫生研究院文献>British Journal of Pharmacology and Chemotherapy >A role for endogenous histamine in interleukin-8-induced neutrophil infiltration into mouse air-pouch: investigation of the modulatory action of systemic and local dexamethasone.
【2h】

A role for endogenous histamine in interleukin-8-induced neutrophil infiltration into mouse air-pouch: investigation of the modulatory action of systemic and local dexamethasone.

机译:内源性组胺在白介素8诱导的中性粒细胞浸润到小鼠气袋中的作用:全身和局部地塞米松的调节作用的研究。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

1. When injected into a 6-day-old mouse air-pouch, human recombinant interleukin-8 (IL-8; 0.03-3 micrograms) induced, in a dose-dependent fashion, an accumulation of neutrophils which could be reliably assessed 4 h after the injection. No protein extravasation was measured above the values obtained with the vehicle alone (carboxymethylcellulose, CMC, 0.5% w/v in phosphate-buffered solution, PBS). 2. The IL-8 effect (routinely evaluated at 1 microgram dose) was inhibited neither by local administration of actinomycin D (1 microgram) nor by systemic treatment with indomethacin (1 mg kg-1, i.v.), BWA4C (5 mg kg-1, p.o.), methysergide (6 mg kg-1, i.p.) and RP67580 (2 mg kg-1, i.p.). 3. Treatment of mice with the H1 antagonist, mepyramine (1-10 mg kg-1, i.p.) resulted in a dose-dependent inhibition of the cell accumulation elicited by the chemokine, with a maximal reduction of approximately 50-60%. The mepyramine effect was not due to a non specific reduction of neutrophil function, since treatment with this drug (6 mg kg-1, i.p.) did not modify the cell infiltration measured in response to a challenge with interleukin-1 beta (20 ng) or with the vehicle CMC to any extent. Moreover, treatment of mice with mepyramine did not modify cell counts in a peripheral blood film with respect to controls. Two other H1 antagonists, chemically unrelated to mepyramine, diphenhydramine (9 mg kg-1, i.p.) and triprolidine (0.5 mg kg-1, i.p.), inhibited IL-8-induced migration to a similar extent (approximately 50-60%), whereas the H2 antagonist, ranitidine (5 mg kg-1, i.p.) was without effect.(ABSTRACT TRUNCATED AT 250 WORDS)
机译:1.当将人类重组白细胞介素8(IL-8; 0.03-3微克)注射到6天大的小鼠气囊中时,它以剂量依赖性方式诱导嗜中性粒细胞积聚,可以可靠地对其进行评估4注射后h。没有测量到超过单独用赋形剂(羧甲基纤维素,CMC,0.5%w / v在磷酸盐缓冲溶液,PBS中)获得的蛋白质外渗。 2.局部给予放线菌素D(1微克)或用吲哚美辛(1 mg kg-1,iv),BWA4C(5 mg kg- 1,po),甲基异麦角酰胺(6 mg kg-1,ip)和RP67580(2 mg kg-1,ip)。 3.用H1拮抗剂美吡拉敏(1-10mg kg-1,腹膜内)治疗小鼠,导致了趋化因子引起的细胞蓄积的剂量依赖性抑制,最大减少了约50-60%。美吡拉敏的作用不是由于嗜中性粒细胞功能的非特异性降低引起的,因为用这种药物(6 mg kg-1,腹膜内)治疗不会改变对白介素-1β(20 ng)的刺激所测得的细胞浸润或与车辆CMC一起使用。而且,相对于对照,用美吡拉明治疗的小鼠没有改变外周血膜中的细胞计数。化学上与美吡拉明,苯海拉明(9 mg kg-1,ip)和曲普立定(0.5 mg kg-1,ip)无关的其他两种H1拮抗剂在相同程度上抑制IL-8诱导的迁移(约50-60%) ,而H2拮抗剂雷尼替丁(5 mg kg-1,ip)无效。(摘要以250字截断)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号